Table 2.
Measure | AD (n = 6) M [SD] |
PD (n = 8) M [SD] |
Neurodegenerative Disease Group (AD+PD) (n = 14) M [SD] |
Comparison Group (n = 18) M [SD] |
---|---|---|---|---|
Far Vision (LogMAR) |
.14 [.08] p = .001* |
−.03 [.09] p = .96 |
.04 [.12] p = .06 |
−.03 [.10] |
Near Vision (LogMAR) |
.15 [.09] p = .02* |
.03 [.04] p = .28 |
.08 [.09] p = .38 |
.05 [.07] |
Contrast Sensitivity | 1.45 [.23] p = .0003* |
1.67 [.10] p = .04* |
1.58 [.19] p = .002* |
1.78 [.14] |
UFOV 2 | 178.60 [102.20] p =.004* |
41.63 [40.79] p = .77 |
94.31 [96.24] p = .15 |
49.83 [72.49] |
UFOV 3 | 363.20 [128.28] p = .02* |
209.00 [134.03] p = .23 |
268.31 [148.53] p = .03* |
161.61 [65.89] |
UFOV 4 | 476.60 [39.02] p = .0002* |
321.13 [129.04] p = .81 |
380.92 [128.13] p = .27 |
333 [107.85] |
UFOV Total | 1074.60 [215.32] p = .0001* |
590.38 [283.98] p = .82 |
776.61 [350.17] p = .07 |
567.89 [209.54] |
COGSTAT | 298.00 [78.43] p = .02* |
368.21 [55.99] p = .09 |
338.13 [73.17] p = .004* |
405.38 [47.22] |
MMSE | 24.50 [4.42] p = .06 |
28.5 [1.60] p = .60 |
26.79 [3.62] p = .07 |
28.78 [1.06] |
Denotes significant differences between comparisons and each of the disease groups.